COVID-19 Vaccine: A comprehensive status report

SP Kaur, V Gupta - Virus research, 2020 - Elsevier
The current COVID-19 pandemic has urged the scientific community internationally to find
answers in terms of therapeutics and vaccines to control SARS-CoV-2. Published …

Skin aging, cellular senescence and natural polyphenols

E Csekes, L Račková - International journal of molecular sciences, 2021 - mdpi.com
The skin, being the barrier organ of the body, is constitutively exposed to various stimuli
impacting its morphology and function. Senescent cells have been found to accumulate with …

Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study

JM Yang, HY Koh, SY Moon, IK Yoo, EK Ha… - Journal of Allergy and …, 2020 - Elsevier
Background There is inconclusive and controversial evidence of the association between
allergic diseases and the risk of adverse clinical outcomes of coronavirus disease 2019 …

[HTML][HTML] Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching

SW Lee, EK Ha, AÖ Yeniova, SY Moon, SY Kim… - Gut, 2021 - gut.bmj.com
Objective The adverse effects of proton pump inhibitors (PPIs) have been documented for
pneumonia; however, there is no consensus regarding whether the use of PPIs might be …

Taste and smell disorders in COVID-19 patients: role of interleukin-6

AP Cazzolla, R Lovero, L Lo Muzio… - ACS chemical …, 2020 - ACS Publications
The rapid recovery of smell and taste functions in COVID-19 patients could be attributed to a
decrease in interleukin-6 levels rather than central nervous system ischemic injury or viral …

SARS‐CoV‐2 infection, COVID‐19 pathogenesis, and exposure to air pollution: What is the connection?

B Woodby, MM Arnold… - Annals of the new York …, 2021 - Wiley Online Library
Exposure to air pollutants has been previously associated with respiratory viral infections,
including influenza, measles, mumps, rhinovirus, and respiratory syncytial virus …

[HTML][HTML] Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2

K Uzunova, E Filipova, V Pavlova, T Vekov - Biomedicine & …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual
outbreak in Wuhan, China, which is caused by severe acute respiratory syndrome …

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection

K Rosenke, K Meade-White, M Letko… - Emerging microbes & …, 2020 - Taylor & Francis
Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently
responsible for millions of infections and hundreds of thousands of deaths worldwide. There …

Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response

A Goyal, EF Cardozo-Ojeda, JT Schiffer - Science advances, 2020 - science.org
To affect the COVID-19 pandemic, lifesaving antiviral therapies must be identified. The
number of clinical trials that can be performed is limited. We developed mathematical …

[HTML][HTML] Male fertility and the COVID-19 pandemic: systematic review of the literature

MA Khalili, K Leisegang, A Majzoub… - The world journal of …, 2020 - ncbi.nlm.nih.gov
Purpose Since its discovery in December 2019, the novel coronavirus SARS-CoV-2 has
spread globally, causing the current COVID-19 (coronavirus disease-19) pandemic. As there …